Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs
J. Clin. Invest. Mikhail V. Blagosklonny, et al. 105:533
doi:10.1172/JCI8625 [Go to this article.]

Problems with a PDF?